These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 447112)

  • 1. Rowachol--a possible treatment for cholesterol gallstones.
    Doran J; Keighley MR; Bell GD
    Gut; 1979 Apr; 20(4):312-7. PubMed ID: 447112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of a terpene mixture inhibits cholesterol nucleation in bile from patients with cholesterol gallstones.
    von Bergmann K; Beck A; Engel C; Leiss O
    Klin Wochenschr; 1987 May; 65(10):458-62. PubMed ID: 3599793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rowachol and ursodeoxycholic acid in hamsters with cholesterol gallstones.
    Handelsman B; Bonorris G; Marks JW; Schoenfield LJ
    Am J Med Sci; 1982; 284(3):16-22. PubMed ID: 7148885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the type of dietary fat on biliary lipid composition and bile lithogenicity in humans with cholesterol gallstone disease.
    Yago MD; González V; Serrano P; Calpena R; Martínez MA; Martínez-Victoria E; Mañas M
    Nutrition; 2005 Mar; 21(3):339-47. PubMed ID: 15797676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity.
    Shaffer EA; Small DM
    J Clin Invest; 1977 May; 59(5):828-40. PubMed ID: 856870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects.
    Northfield TC; LaRusso NF; Hofmann AF; Thistle JL
    Gut; 1975 Jan; 16(1):12-7. PubMed ID: 1140620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of loss of gallbladder function on biliary lipid composition in subjects with cholesterol gallstones.
    Redinger RN
    Gastroenterology; 1976 Sep; 71(3):470-4. PubMed ID: 950098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic biliary lipid secretion and gall bladder biliary lipid mass in gall stone patients: effect of ursodeoxycholic acid.
    Lanzini A; Northfield TC
    Gut; 1990 Feb; 31(2):226-30. PubMed ID: 2311984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent secretion of abnormal bile in patients with cholesterol gall stones.
    Smallwood RA; Jablonski P; Watts JM
    Br Med J; 1972 Nov; 4(5835):263-6. PubMed ID: 5083887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallstone formation and dissolution.
    Morrissey KP
    Major Probl Clin Surg; 1982; 16():61-100. PubMed ID: 7054618
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of Rowachol on biliary lipid secretion and serum lipids in normal volunteers.
    Leiss O; von Bergmann K
    Gut; 1985 Jan; 26(1):32-7. PubMed ID: 3965364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supersaturated bile--is it due to a metabolic disorder or to an impaired gallbladder?
    Scherstén T; Cahlin E; Jönsson J; Lindblad L; Nilsson S
    Scand J Gastroenterol; 1974; 9(5):501-6. PubMed ID: 4854529
    [No Abstract]   [Full Text] [Related]  

  • 13. Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects.
    Northfield TC; Hofmann AF
    Gut; 1975 Jan; 16(1):1-11. PubMed ID: 806491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile acid pools, kinetics and biliary lipid composition before and after cholecystectomy.
    Almond HR; Vlahcevic ZR; Bell CC; Gregory DH; Swell L
    N Engl J Med; 1973 Dec; 289(23):1213-6. PubMed ID: 4748594
    [No Abstract]   [Full Text] [Related]  

  • 15. Bile lipid secretion in obese and non-obese individuals with and without gallstones.
    Reuben A; Maton PN; Murphy GM; Dowling RH
    Clin Sci (Lond); 1985 Jul; 69(1):71-9. PubMed ID: 4064557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in hepatic bile composition following cholecystectomy in patients with previous gallstones.
    Boyer JL; Bloomer JR; Maddrey WC; Tilson D
    Yale J Biol Med; 1974 Dec; 47(4):211-7. PubMed ID: 4456833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid composition and cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones under choleretic treatment with Febuprol.
    Jüngst D; Brenner G; Pratschke E; Paumgartner G
    Z Gastroenterol; 1988 May; 26(5):275-8. PubMed ID: 3407249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sodium acetyl salicylate on cholesterol saturation of fasting gall bladder bile, with and without chenic acid.
    Kupfer RM; Northfield TC
    Br J Clin Pharmacol; 1983 Jan; 15(1):114-6. PubMed ID: 6849734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rowachol, a proprietary terpene preparation, dissolves cholesterol gallstones [proceedings].
    Bell CD; Doran J; Middleton A; Middleton B; Richmond CR; White DA
    Br J Clin Pharmacol; 1978 Nov; 6(5):454P. PubMed ID: 728305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.